Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

hMedicine Archive

Showing 321 to 340 of 350      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 | Next | Last
Hadassah Celebrates 36th Class of International Public Health Graduates
Nineteen students from countries as diverse as Ethiopia and China were graduated this year from the International Masters in Public Health Program (IMPH) of the Hadassah-Hebrew University Braun School of Public Health. Date: 11/14/2011


Hadassah University Medical Center’s Prof. Jacque Michel Honored for 10 Years as Head of Helsinki Committee
Prof. Jacque Michel, former Director of Hadassah Hospital-Mount Scopus and Volunteer Chair of the Hadassah University Medical Center’s Helsinki Committee for the past 10 years, was honored by Hadassah during a special seminar on Ethics in Medicine. Date: 11/14/2011


Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells
Since 1990, the Multiple Sclerosis (MS) Center at the Hadassah University Medical Center has been conducting groundbreaking research into the use of bone marrow-derived stem cells to treat MS. Today, Hadassah’s MS Center, headed by Prof. Dimitrios Karussis, is a world leader in treating MS with stem cells. Date: 11/14/2011


Honors for Hadassah University Medical Center Intensive Care Pioneer
Prof. Charles Sprung, Director of the Intensive Care Unit at Hadassah Hospital-Ein Kerem, has been honored by The European Society of Intensive Care Medicine (ESICM) with the Society's 2011 Medal, its most prestigious award. In his letter to Prof. Sprung, President Andrew Rhodes wrote: "Your leadership has changed the way intensive care medicine is viewed and has led to significant advances and improvements in the standards of care." Date: 11/14/2011


Israel’s President Shimon Peres Toasts Hadassah as a Role Model for Peacemaking
"No institution models a place of complete peace under the most demanding circumstances more than Hadassah," Israel's President Shimon Peres said at a special September reception welcoming the new Hadassah National President Marcie Natan. Date: 11/14/2011


Researchers Identify Gene Involved in Ovarian Development
A teenage girl who came to the Hadassah University Medical Center for help when she did not go through puberty, led to the discovery of a gene that plays a major role in ovarian development. The three-year investigation was conducted by a joint team from Hadassah and Shaare Zedek Medical Center, led by Dr. David Zangen, head of Hadassah’s Pediatric Endocrinology Unit, and Prof. Ephrat Levy-Lahad, head of the Medical Genetics Institute at Shaare Zedek. Date: 11/14/2011


Spotlight on Hadassah’s Dr. Yael Houri-Haddad: Specialist in Oral Biology
Dr. Yael Houri-Haddad, who immigrated to Israel from Tunisia at age 14, is a Hadassah University Medical Center dentist with a PhD in oral biology. She acquired both specialties at Hadassah where she now teaches, treats patients, and conducts research in the Department of Prosthodontics at the Hadassah Hebrew University School of Dental Medicine. Date: 11/14/2011


The Call Every Parent Dreads: the Story of a Car Accident, Hadassah Trauma Expertise, and a Happy Ending
"I knew it was bad when I saw my wife's knees buckle and her hand grasped the wall for support. Our son Yaakov, 21, was hit by a car," relates Ephraim Shore, a well-known educator at the Aish HaTorah Yeshiva in Jerusalem. Date: 11/14/2011


Artist who Severed His Hand Has Ability to Paint Again Thanks to Hadassah University Medical Center
Although he severely severed the palm of his hand, Sa'ad El-Kikh, an artist from the village of Tsurif near Hebron, is able to draw and paint once again thanks to a special tool affixed to his hand by Hadassah University Medical Center physical therapists. Date: 10/24/2011


Clinical Trial at Hadassah Hospital Yields Positive Results With Noninvasive Test for Liver Cancer
A clinical trial conducted at the Hadassah University Medical Center has revealed that BreathID, a new noninvasive device for the detection of hepato-cellular carcinoma, a type of liver cancer, achieved diagnostic results similar to CT Scans and MRIs. BreathID was developed by Exalenz Bioscience Ltd., whose Medical Director is Prof. Yaron Ilan, Director of Hadassah's Department of Internal Medicine. Date: 10/24/2011


Clinical Trial Begins at Hadassah University Medical Center with New Drug to Treat Stroke
A Phase IIa clinical trial with a medicine to treat ischemic stroke has begun at Hadassah, based on the research of Prof. Abd Al-Roof Higazi, head of the Department of Clinical Biochemistry at Ein-Kerem. Date: 10/24/2011


Diabetes Cure Moves a Step Closer with new Hadassah/Hebrew University Research
Hope for a future cure of insulin-dependent (type 1) diabetes received a boost from the research findings of a multi-year project. Read about it Date: 10/24/2011


Hadassah Medical Center Professor Elected "Director at Large" for Prestigious Radiopharmaceutical Society
Prof. Eyal Mishani, who established Hadassah's Cyclotron Radiochemistry Unit, was elected to serve as "Director at Large" on the five-member Executive of the Society of Radiopharmaceutical Sciences (SRS). Date: 10/24/2011


Hadassah Medical School Graduate Named Chief Executive Officer of Harvard’s Teaching Hospital--Beth Israel Deaconess Medical Center
Dr. Kevin Tabb, a graduate of the Hadassah-Hebrew University School of Medicine, is the new President and CEO of Beth Israel Deaconess Medical Center, the teaching hospital of Harvard University. Date: 10/24/2011


Hadassah Physician Predicts Use of Medical Marijuana Will Grow
The number of authorizations for medical marijuana could reach as high as 40,000 in the next five years, predicts Dr. Elyad Davidson of the Hadassah University Medical Center's Pain Management Clinic. Date: 10/24/2011


Hadassah’s Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration
Hadassah's Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration Hadassah's National Physicians Council will be hosting a pre-Centennial Convention Continuing Education Program in Jerusalem, Oct. 14-15, 2012. Date: 10/24/2011


Liver Disease Early Diagnosis Device Developed at Hadassah Medical Center Receives Exemption from FDA, Providing Fast Track for Approval
BreathID, a noninvasive early diagnosis device for acute liver failure developed at the Hadassah University Medical Center, has been fast-tracked by the FDA toward approval. Date: 10/24/2011


Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome
"In pre-clinical studies," notes Prof. Raphael Gorodetsky, head of the Biotechnology and Radiobiology Laboratory at the Sharrett Institute of Oncology at Hadassah University Medical Center, "we found that placental-derived cells potentially have the ability to increase the survival rate of animals following exposure to lethal doses of total body irradiation." Date: 10/24/2011


Reunion at Hadassah Commemorates Saving of Life by Organ Recipient Families who Later Became Organ Donors
Three families whose lives were intertwined by organ transplantation reunited recently at Hadassah University Medical Center to commemorate the saving of life following the tragic death of loved ones. Date: 10/24/2011


Saving a Toddler with a Huge Liver Tumor: a Hadassah Patient Success Story
Diagnosed with an extremely large liver tumor, two-year-old Ilana was treated by the Hadassah University Medical Center’s multidisciplinary team with an individualized course of chemotherapy directly into the arteries of her liver. Despite the difficulty of such a procedure in a small child weighing less than 22 pounds, Ilana is now a happy, healthy baby. Date: 10/24/2011


Showing 321 to 340 of 350      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 | Next | Last


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

    |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America